| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.1 | 0.5 |